A University of Houston pharmacology researcher and expert in cardiac development has identified a new cause of—and repair for—left ventricular non-compaction, also known as spongy heart disease. The new therapeutic approach, performed in…
Continue Reading
News Source: medicalxpress.com
Leave a Reply